Health Exact Sciences (EXAS) Crossed Above the 20-Day Moving Average: What That Means for Investors December 19, 2022
Biotechnology CRISPR Therapeutics Announces the Appointment of Alex Harding, M.D., M.B.A., as Head of Business Development December 19, 2022
Health Biogen Reaches Agreement with Genentech to Receive Royalties on the Potential Commercialization of a Late-Stage Bispecific Antibody as Part of Anti-CD20 Collaboration December 19, 2022
Tech SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZNP, COUP, FRBA, MLVF December 18, 2022
Health U.S. FDA Approves VRAYLAR® (cariprazine) as an Adjunctive Treatment for Major Depressive Disorder December 16, 2022